Rekombinanter TAG-72 (Minretumomab Biosimilar) Antikörper

Produktnummer ABIN7795096

Der Humanized Monoklonal anti-TAG-72 (Minretumomab Biosimilar) Antikörper (ABIN7795096) detektiert spezifisch TAG-72 (Minretumomab Biosimilar) in FACS und in vivo. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für Rekombinanter TAG-72 (Minretumomab Biosimilar) Antikörper (ABIN7795096)

Target: TAG-72 (Minretumomab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Humanized

Klonalität: Monoklonal

Konjugat: Dieser TAG-72 (Minretumomab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), In vivo Studies (in vivo)

Güteklasse: Research Grade

Produktdetails anti-TAG-72 (Minretumomab Biosimilar) Antikörper

Expressionssystem: Mammalian cells

Verwendungszweck: Minretumomab Biosimilar, TAG-72 Monoclonal Antibody

Produktmerkmale: Minretumomab Biosimilar uses the same protein sequences as the therapeutic antibody minretumomab. Minretumomab is a mouse monoclonal antibody that was designed for the treatment of cancers that express the TAG-72 antigen. This includes breast, colon, lung, and pancreatic cancers. A wide range of derivatives has been used in pharmaceutical research. Examples include chimeric and humanized minretumomab, as well as a fusion protein of a minretumomab single-chain variable fragment and the enzyme beta-lactamase.

Aufreinigung: Protein A or G affinity column

Reinheit: >95 % by reducing SDS-PAGE

Endotoxin-Niveau: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human TAG-72

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: > 3 mg/mL

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Details zu TAG-72 (Minretumomab Biosimilar)

Target: TAG-72 (Minretumomab Biosimilar)

Andere Bezeichnung: Minretumomab Biosimilar

Substanzklasse: Biosimilar